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One of the possible causes of failure of the mechanochemical activation of poorly
soluble drugs relies on the scarce drug wettability. Indeed, the mechanochemical process
comports the disposition of drug nano-crystals and amorphous drug, generated by the de-
struction of original drug macro-crystals, on the surface of the carrier (acting as stabi-
liser), usually represented by crosslinked polymeric particles. Accordingly, the scarce
drug wettability can reduce the beneficial action of mechanochemical activation
(nano-crystals and amorphous drug are characterised by a higher solubility with respect
to the original macro-crystals). In this light, this paper is focussed on the use of surfac-
tants for the increase of delivery system (drug plus carrier) wettability. In particular, the
surfactant-polymer systems are characterised for what concerns their bulk and surface
properties. This allows to select the best surfactant and to experimentally verify its effect
on the release kinetics of a poorly soluble and wettable drug.
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Introduction
Oral dosage form represents the most common
route for drug administration into human body be-
cause it leads to a better patient compliance and it is
very versatile for what concerns dosing conditions
1,2. Unfortunately, however, oral dosage form can be
not so effective due to poor drug solubility in aque-
ous environments such as physiological media. In-
deed, solubility is an important requirement to en-
sure good body absorption after oral administration.
In other words, pharmaceutical system bioavail-
ability, defined as the rate and extent to which the
active drug is absorbed from a pharmaceutical form
and becomes available at the drug action site3, is
heavily influenced by drug solubility that becomes
the absorption rate determining step for class II
drugs (good permeability, poor solubility) accord-
ing to the Amidon biopharmaceutical classifica-
tion4. While an ideal drug (100% bioavailability)
gets the site of action unmodified without undergo-
ing metabolism and elimination pathways, a real
one, especially if slightly bioavailable, has to be ad-
ministrated in high dose to ensure a minimum ef-
fective concentration at the site of action. In this
case, consequently, the appearance of dose-depend-
ing side effects can be probable. A possible strategy
to improve solubility and, thus, bioavailability,
without modifying drug chemical structure, strictly
connected to therapeutic properties, is to act on
drug physical properties. Indeed, it is well known5
that the smaller the drug crystal, the higher its solu-
bility in a liquid system. This statement, a little bit
intriguing, neither represents a paradox, nor con-
futes thermodynamic theory. Indeed, at fixed tem-
perature and pressure, drug solubility in a solvent is
a unique value descending from the principle of
minimal energy that translates into the equality of
all species chemical potential in the liquid and solid
phase. In virtue of the minimal energy principle,
however, this definition of solubility implicitly as-
sumes that the solid phase is represented by crystals
of infinite dimension, this being the most stable
configuration the solid phase can assume. If, on the
contrary, it were possible to realise the equilibrium
between a liquid phase and a solid one made by
very small crystals (nano-crystals or, more pre-
cisely, crystallites), it can be thermodynamically
demonstrated that drug solubility is dependent on
crystals size5. However, as nano-crystals represent a
metastable condition for the solid phase and they
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tend to assemble together to get the most stable in-
finite crystal condition, it is not experimentally pos-
sible to achieve a two phases “equilibrium” in pres-
ence of a nano-solid phase. Nevertheless, in the
presence of particular stabilising agents, the
metastable nano-crystals condition can be stabilised
and, at least for a limited period, it is possible to
take advantage of the increased solubility6. Obvi-
ously, the amorphous drug condition can be viewed
as a nano-crystal of vanishing dimension which
competes the highest solubility in a solvent at fixed
temperature and pressure7. In this sense, both
nano-crystals and amorphous phase represent an ac-
tivated state for the drug.
It is now clear the necessity of choosing a
proper stabilising agent to have a reliable and effec-
tive delivery system able to take advantage from
the above discussed nano-crystals property. De-
pending on drug physicochemical characteristics,
particular polymers (typically crosslinked amphi-
philic ones) can stabilise nano-crystals and amor-
phous drug phase by trapping them inside their
three-dimensional network or on their surface. In-
deed, due to polymer – drug interactions and to the
physical presence of the polymeric chains (drug
macro-crystals can form on condition that the dry
network meshes be sufficiently wide), macro-crys-
tals formation, at least in the dry state, is practically
hindered5,6. On the contrary, when polymeric parti-
cles come into contact with the external liquid envi-
ronment, solvent diffusion inside the polymeric net-
work gives rise to the swelling process and to drug
dissolution, coupled with nano-crystals and amor-
phous drug re-crystallisation into macro-crystals.
The presence of the solvent and the enlarged di-
mensions of the network meshes make negligible
the polymer stabilising action. Practically, release
kinetics develops as the dissolving drug were char-
acterised by a decreasing solubility, spanning from
a higher value to a lower one, characteristic of the
macro-crystal8,9. As re-crystallisation is not instan-
taneous, on average, drug release kinetics is im-
proved5, 6.
Although different techniques exist to disperse
the drug inside the polymeric network (solvent
swelling6,10 and supercritical fluids11,12, for exam-
ple), in form of very small crystals ranging from the
nano-scale to the virtually zero-dimensional crys-
tals representing by the amorphous state, co-grind-
ing proved to be a reliable strategy13–15. Moreover,
it has the considerable advantage of not requiring
the use of solvents whose elimination from the final
formulation can often represent a very expensive
and delicate stage. Indeed, solvent must be elimi-
nated without extracting the drug and without mod-
ifying drug distribution inside the polymer as it is
well known that this distribution can sensibly affect
the release kinetics16,17. Unfortunately, however,
when the drug is highly hydrophobic and its abun-
dance in the co-ground system is relevant
(drug-polymer ratio  1/3 w/w) delivery system
wettability can be very low18. In this case, despite
of good drug activation, bioavailability can be de-
pressed and the use of surfactants becomes un-
avoidable. Accordingly, aim of this work was to
study polymer-surfactant interactions in order to se-
lect the best candidate able to confer the highest
wettability to the carrier system (polymer) which,
in turn, reflects on the improvement of the whole
drug-polymer system wettability. Firstly, poly-
mer-surfactant bulk properties were studied in order
to measure surfactant solubility in the polymeric
bulk phase. Then, attention was focussed on the
polymer-surfactant system surface properties. In-
deed, it is essential to evaluate whether surfactant
disposes at the solid surface or not as system
wettability modifications are only due to the super-
ficial surfactant fraction. Finally, in vitro release
tests were used to evaluate the macroscopic effect
of surfactants on release kinetics.
Materials and methods
In the light of its amphiphilic nature and of its
wide use as drug nano-crystals stabilizer5,6,10,15,
polyvinyl-pyrrolidone (PVP) was chosen as poly-
meric carrier. In particular, two PVP types were
used: the linear one (K90, Kollidon BASF) and the
crosslinked one (polyvinyl-pyrrolidone, PVP-CL-M.)
Investigated surfactants were sodium lauryl sulfate
(SLS, anionic, Sigma Aldrich), tetradecyl trimetyl
ammonium bromide (TTAB, cationic, Sigma
Aldrich) and poloxamer 407 (Lutrol, not ionic,
Sigma Aldrich). All of them are approved for oral
administration and frequently employed in formu-
lations19,20. Nimesulide (Helsinn, PambioNoranco,
CH), a typical non-steroidal anti-inflammatory drug
(NSAID), was considered as model drug as it be-
longs to the Amidon class II (low solubility and
high permeability drug)4 and for its low wett-
ability21.
Determination of bulk properties
K90 aqueous solutions (7% w/w) containing
different surfactant amounts, were prepared, poured
in aluminium pans and there dried (drying over-
night under air flux followed by 40 minutes at 80°C
in a oven) to get films. Differential scanning
calorimetry (Perkin Elmer DSC 7, Perkin Elmer,
Norwalk, CT) was then led on these films to deter-
mine the polymer-surfactant phase diagram and,
thus, surfactant solubility in the polymer reach
phase (temperature calibration was made, at the
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same heating rate, using Hg and In as standards). In
order to eliminate water traces, films underwent a
first heating step led at 10°C/min (SLS, from 50°C
to 190°C; TTAB, from 20°C to 110°C; Lutrol from
20°C to 180°C) followed by an analogous cooling.
Then, 1 minute isotherm (SLS 50°C; TTAB 20°C;
Lutrol 20°C) preceded the definitive heating (SLS,
up to 200°C; TTAB up to 190°C; Lutrol up to
190°C) at 10°C/min. DSC scans were performed
under N2 stream (20 cm
3/min) to prevent samples
from oxidation.
DSC analysis was firstly addressed to deter-
mine the variations of polymer glass transition tem-
perature (Tg). Indeed, Tg, characteristic of each
amorphous polymer, decreases with increasing
surfactant concentration because of surfactant plas-
tic agent action. Then, first order transitions (melt-
ing), characteristic of crystalline surfactants, were
considered in order to individuate the eventual pres-
ence of a surfactant reach phase, being the polymer
reach one the only phase existing until surfactant
solubility in the polymer was not exceeded.
X-Ray diffraction analysis (Stoe 500, Siemens,
Germany, equipped by a Cu K source (40KV,
20 mA)) allowed getting information on possible
film crystalline structure due to the presence of a
surfactant reach phase.The scanning angle ranged
from 5 to 35° of 2, steps were of 0.05° of 2, and
the counting time was of 5 s/step.This technique
was used to support what found by means of DSC
analysis.
Determination of surface properties
K90-surfactant films, characterised by different
surfactant mass fraction (up to 7% for SLS and up
to 9% for TTAB. This characterisation was not per-
formed in the case of Lutrol for the reasons exposed
in the results and discussion section), were prepared
by casting the polymer-surfactant aqueous solution
on a glass support. Water evaporation was per-
formed under controlled conditions in order to get a
homogeneous surface free from cracks and bubbles.
Films surface properties were firstly determined by
measuring the contact angle (tensiometer G10,
Kruss, GmbH, Hamburg, D; sessile drop technique)
relative to a polar solvent (distilled water) and an
apolar one (diiodomethane). Then, in order to ver-
ify the existence of one or two phases on film sur-
face, the Cassie-Baxter equation22 was used:
cos a = f1 cos 1 + f2 cos 2 (1)
where a is the apparent contact angle measured on
film surface while f1 and f2 are the surface fractions
occupied by the two phases, each one characterized
by its own contact angle (1 and 2). As, obviously,
f1 + f2 = 1, eq.(1) becomes:
cos a = f1 (cos 1 – cos 2 ) + cos 2 (2)
which expresses a linear dependence of cos a
on f1. Thus, if the experimental trend of cos a is
not linear with f1, it is not possible that two superfi-
cial phases exist on film surface.
To further characterize films surface properties,
their solid-liquid (sl) and solid-vapor (sv) surface
tensions were determined. At this purpose, Young
equation23 was used:
lv cos  = sv – sl (3)
where  is the contact angle and lv is the liquid-va-
por surface tension competing to the probe liquid
used to wet film surface. As in eq.(3) sv is un-
known, its value was estimated according to the Wu
approach24. This approach relies on the hypothesis
that sv is the sum of two contributes:
sv =  sv
d +  sv
p (4)
where  sv
d is the dispersional component and  sv
p is
the polar component. In addition, assuming that the
mean interaction potential relative to the two im-
miscible phases (the liquid and the solid phase, in
our case) is given by the harmonic mean of the in-
teraction potential of each phase, Wu got the fol-
lowing relation:
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and the polar component of lv. While  lv
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p are unknowns. Accordingly, their determi-
nation implies the simultaneous solution of two
equations of the eq.(5) type relative to two different
liquids. In so doing, the balance among equations
and unknowns ( sv
d and  sv
p ) is achieved as, obvi-
ously,  sv
d and  sv
p do not depend on the liquid used
but they depend only on the solid film surface char-
acteristics. In particular, in this work, two different
liquids were considered: distilled water and
diiodomethane. Indeed, while water is essentially
polar, diiodomethane is essentially apolar. Once  sv
d
and  sv
p are known, eq.(4) allows the determination
of sv. On this basis, eq.(3) yields sl when the
solid-liquid contact angle () has been experimen-
tally determined. Knowledge of sv is not only im-
portant per se, but it is also essential for the deter-
mination of the film surface composition in relation
to different surfactant concentration in the film
bulk. Indeed, for a two components (1 = polymer,
2 = surfactant) system made up by a vapor (v) and a
solid (s) phase in equilibrium, Gibb-Duhem equa-
tions hold25:
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n nv v v v1 1 2 2 0d d   (6)
n ns s s s1 1 2 2 0d d   (7)
where n v1 and n
v
2 represent, respectively, the moles
of polymer and surfactant in the vapor phase, n s1
and n s2 represent, respectively, the moles of polymer
and surfactant in the solid phase (film) while
d d d  1 1 1
v s  and d d d  2 2 2
v s are, respec-
tively, the infinitesimal variation of polymer and
surfactant chemical potential. Eqs.(6) and (7) can
be coupled with the Gibb’s equation pertinent to the
solid-liquid interface22:
d d d  sv
sv sv 	 	
 





sv are, respectively, the so called
excess of polymer and surfactant on the solid-vapor
interface. According to the Gibb’s theory22, when

i
sv (i = 1 or 2 in our case) is equal to zero, the sur-
face and the bulk composition of component ith are
equal, i.e, the excess (or defect) of component ith on
the surface is zero. Expressing d1 dependence on
d2 according to eq.(6) and substituting this expres-
sion into eq.(8), we get:





























Remembering the relation existing between the
chemical potential and activity (d2 = RT d ln a2;
where T indicates the absolute temperature, R is the













As in the case of diluted solutions (surfactant
concentration less than 0.1), surfactant activity (a2)
can be approximated by its concentration (c2),













Relying on eq.(12), it is easy to verify the va-


























In order to investigate the polymer-surfactant
interaction in liquid phase, different aqueous solu-
tion (polymer concentration = 10 mg/cm3) with in-
creasing surfactant concentrations (spanning from
10 to 10000 g/ml) were prepared. Then, liquid-va-
por surface tension was measured by means of a
tensiometer G10 (Krûss GmbH, Hamburg, D, pen-
dant drop technique). In the case of important inter-
actions between the polymer and the surfactant,
variations in the lv versus ln(c2) should be de-
tected26. Both K90 and PVP-Clm were used. Obvi-
ously, in the case of PVP-Clm, we were in presence
of dispersions and not of solutions due to
cross-linked nature of PVP-Clm.
Preparation and calorimetric investigation
of co-ground samples
Nimesulide/PVP-CL-M/surfactant physical mix-
ture (ratio 11:32:1 (w/w)) and Nimesulide/PVP-CL-M
physical mixture (ratio 11:33 (w/w) were co-ground
for 2 hours in a planetary mill (Pulverisette 7,
Fritsch GmbH, D)) setting the rotational speed to
530 rpm. Mill vials, made up by agate, contained
seven agate balls (1 cm diameter) plus 1.5 g of
physical mixture. The planetary mill was chosen as
it is efficient and its dynamic behaviour, jointly
with the energy transfer to co-ground materials, is
well understood27. The co-ground material was
sieved (60 mesh – 250 m). Pure nimesulide and
different co-ground systems were characterised by
means of DSC. The samples were put into alu-
minium pans (about 6–7 mg in the case of
co-ground systems and about 2 mg in the case of
pure drug) and then scanned under a N2 stream of
20 cm3/min at a heating rate of 10 °C/min. In order
to eliminate water from the co-ground materials, a
four step procedure was applied: 1) heating from
20°C to 90°C 2) cooling from 90°C to 70°C 3) rest-




Release tests, performed in triplicate in not
sink conditions, were led in 600 cm3 water (Vr) at
37°C. At time zero, 200 mg of physical mixture
(nimesulide/PVP-CL-M, 11:33 weight ratio, simply
mixed) or co-ground systems (nimesulide/PVP-CL-M,
weight ratio 11:33, mixed and then subjected to
co-grinding; Nimesulide/PVP-CL-M/surfactant
weight ratio 11:32:1, mixed and then subjected to
co-grinding) were added to the release environ-
ment. The reason for choosing this drug-polymer
ratio relies on the fact that lower ratios are not
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probably connected to wettability problems due to
polymer abundance. On the contrary, higher ratios
would reflect in poorly stable systems due to the
polymer lack.
Drug
In the case of pure nimesulide, 50 mg of drug
were added to the release environment (600 cm3
water (Vr) at 37°C). In so doing, the drug dose is the
same used in the test performed on the drug-poly-
mer system.
Operative conditions
Uniformity conditions were ensured by means
of an impeller (rotational speed 200 rpm). The use
of an optical fibre apparatus (HELLMA, Italy),
connected to a spectrophotometer (ZEISS, Ger-
many, wavelength 393.4 nm), allowed the determi-
nation of nimesulide concentration (Cr) without per-
turbing the release environment (each release test
lasted 20 minutes). Moreover, this methodology al-
lowed to easily overcome the problem connected to
drug concentration measurement in presence of a
dispersion of solid particles. Indeed, while the max-
imum nimesulide absorption occurred at 393.4 nm,
the scattering effect due to polymeric particles uni-
formly occurred at every wavelength. Accordingly,
the real absorbance related to nimesulide concentra-
tion was the difference between the absorbance
measured at 393.4 nm and that measured at 500 nm
(at 500 nm nimesulide does not absorb).
Results and discussion
Bulk properties
Figure 1, showing the DSC behaviour relative
to K90, reveals that this amorphous polymer is
characterised by an inflection with a midpoint at
174°C, attributable to its glass transition tempera-
ture (Tg), followed by a relaxation endotherm. At
the same time, Figure 2 shows that two thermal
events characterise the DSC pattern of SLS: the
first, occurring at 87°C, represents a solid-solid
transition while the second, positioned at 196°C, in-
dicates the solid-liquid phase transition. These con-
siderations were supported by the hot stage micros-
copy studies (FP 52 Mettler, Greifensee, CH, con-
nected to a temperature controller FP 5 Mettler)
(data not shown).
Indeed, while no liquid phase was visible at
87°C, an evident liquid phase appeared at 196°C.
The information contained in Figure 1 and 2 repre-
sent the initial (0% SLS content) and final part
(100% SLS content) of the K90-SLS phase diagram
reported in Figure 3. Figure 3 was realised by per-
forming a DSC analysis on different K90-SLS sys-
tems characterised by an increasing content (mass
fraction X 100) of SLS21. Accordingly, all the ther-
mal events characterising the different K90-SLS
systems were recorded and reported in the phase di-
agram of Figure 3. It can be seen that, up to a SLS
content of about 9%, only one phase exists and the
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F i g . 1 – DSC pattern of K90. Endothermic peak is upward
F i g . 2 – DSC pattern of SLS. Endothermic peak is upward
F i g . 3 – SLS-K90 phase diagram
increase of SLS content simply reflects into a re-
duction of the Tg competing to the K90-SLS sys-
tem. This is reasonable as SLS, acting as a
plasticizer agent, enhances K90 molecules mobility.
Obviously, once temperature T exceeds Tg, the glass
phase transforms into a rubber phase. As soon as
SLS content exceeds 9%, DSC analysis reveals the
presence of a bi-phasic system composed by a K90
reach phase and an SLS reach phase.
Indeed, other three thermal events add to the
original one referring to the glass-rubber transition.
Accordingly, up to  87°C (pure SLS solid-solid
transition) we have the coexistence of a glass phase,
rich in K90, and a solid phase, rich in SLS, de-
nominated polymorphic 1. A temperature increase
induces the transformation of the SLS-rich phase
in the polymorphic 2 state while being unaffected
the glass phase. Depending on the SLS content,
this second biphasic region spans from  87°C to
115 – 150°C. Once this threshold is overcome, the
glass phase becomes rubber while no modifications
are observed in the SLS-rich phase (polymorphic
2). A further temperature increase reflects into the
formation of new SLS-rich phase denominated
“solid 3”. This biphasic region spans between
167°C and 196°C, regardless of SLS content. As
the “solid 3” phase cannot be detected in the pure
SLS (no thermal event occurs around 167°C, see
Figure 2) we should suppose that solid 3 is induced
by the presence of K90. After 196°C, the coexis-
tence of a rubber, K90 rich, phase and a liquid, SLS
rich, phase takes place.
In order to support the existence of only one
phase for SLS < 9% and the existence of two
phases for higher SLS content, X-ray diffraction
pattern were recorded for K90, SLS and two different
K90-SLS systems (SLS = 5% and SLS = 28.6%).
Figure 4 and 5 show, respectively, the comparison
between the X-ray pattern relative to the couples
(K90 and K90-SLS 5%) and (SLS and K90-SLS
28.6%).
It is clear that in the K90-SLS 5% system the
peaks characteristic of SLS are not visible while a
diffraction pattern very similar to that of K90 ap-
pears. This means that, in this case, no solid phase
is present and only one amorphous phase exists. On
the contrary, in the K90-SLS 28.6%, some of the
peaks, characteristic of pure SLS, are present and
this witnesses the presence of a solid phase rich in
SLS. In addition, the X-ray pattern relative to the
K90 rich phase is detectable.
The phase diagram relative to the K90-TTAB
system, reported in Figure 6, was built according to
the same procedure followed for the determination
of the K90-SLS phase diagram. We can see that for
TTAB contents lower than 10% only one phase ex-
ists and system Tg, correctly, decreases with in-
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F i g . 4 – X-rays pattern relative to K90-SLS 5% and K90
systems
F i g . 5 – X-rays pattern relative to K90-SLS 28.6% and SLS
systems
F i g . 6 – TTAB-K90 phase diagram
creasing TTAB concentration. Once this threshold
is exceeded, a bi-phasic condition occurs: a K90
rich phase coexists with a TTAB rich phase. Indeed,
the DSC trace shows the appearance of the TTAB
solid-liquid transition (around 100°C) plus another
peak that indicates the Tg of the K90 rich system.
Accordingly, when TTAB content exceeds 10%, a
temperature rise gives origin to the phase transfor-
mations reported in Figure 6. For TTAB content ex-
ceeding 60%, the phase diagram is not so clear due
to the disappearance of the Tg peak. Anyway, this
region is not of practical interest due to the very
high surfactant content. Obviously, also in this case,
the X-ray analysis, performed on three different
systems (K90-TTAB 3%, 7% and 50%), revealed
that only one phase exists for TTAB contents lower
than 10% while a two-phase system appears for
higher concentrations.
Finally, Figure 7, showing the K90-Lutrol
phase diagram, makes clear that the solubility of
this surfactant inside K90 is very limited (around
0.5%). Accordingly, its use in combination with
K90 seemed not promising.
Surface properties
Table 1 reports the water (H2O) and the
diiodomethane (CH2I2) contact angles relative to
K90-SLS films characterized by increasing amount
of SLS up to 7%, i.e., just below SLS solubility in
the K90-SLS system (see Figure 1). These data re-
veal that while the increase of SLS amount does not
reflect in systematic variations of H2O, SLS in-
crease implies an increase of CH2I2. In addition, it is
easy to verify that the trend of cos() versus %SLS
(= f1), for both water and diiodomethane, does not
follows a linear trend as it should be according to
the Cassie-Baxter equation (eq.(2)). Thus, we can
conclude that only one phase exists at the K90-SLS
film solid-vapor interface. This is in agreement with
what found by means of the bulk characterization
(see K90-SLS phase diagram reported in Figure 1).
Table 1 also shows that, according to eq.(5), the in-
crease of SLS reflects into a convex variation of sv
(minimum value around 4%) while the polar com-
ponent ( sv
p ) increases and the dispersional com-
ponent ( sv
d ) decreases. The addition of SLS makes
the surface more hydrophilic and, consequently,
more wettable by water.
On the basis of the sv dependence on the
amount of SLS (see Table 1), it was possible eva-
luating the excess of polymer (
1
sv ) and surfactant
( )
2
sv on the solid-vapor interface according to
eqs.(12)-(14). At this purpose SLS content, ex-
pressed as mass fraction X 100, was converted into
molar concentration (moles/m3) knowing that poly-
mer and SLS molecular weights are, respectively,
106 and 288.4 and that film density is, in the range
0 < SLS%  7%, approximately equal to 885 Kg/m3.
Thus, the resulting svvs. ln(c2) curve was fitted by
the following equation:
sv = A (ln(c2))
3 + D (ln(c2))
2 + E (ln(c2)) + F (15)
and the values of the fitting parameters were: A = 9.3,
D = –110.4, E = 419.0 and F = –446.8. Relying on
eq.(15), (dsv/dln(c2)) was determined and, conse-
quently, 
 (see eq(12)) could be evaluated for all
the experimentally tested B ( n n c cs s2 1 2 1) val-
ues. The pseudo-experimental trend of 
 versus B
was fitted by the following equation:
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F i g . 7 – Lutrol-K90 phase diagram
T a b l e 1 – Water contact angle (H2O) ± standard deviation,
diiodomethane contact angle (CH2I2) ± standard deviation, po-
lar ( lv
p ) and dispersional ( lv
d ) liquid-vapor surface tension rel-
ative to water and diiodomethane, solid-vapor surface tension
(sv), polar ( sv
p ) and dispersional ( sv
d ) solid-vapor surface ten-
sion relative to K90-SLS films characterized by increasing
















0 55 ± 1 17 ± 1 64.2 19.0 45.2
1 46 ± 3 25 ± 1 67.1 24.0 43.0
2 56 ± 2 42 ± 2 57.0 20.6 36.4
3 60 ± 2 55 ± 3 50.8 20.7 30.1
4 55 ± 4 64 ± 3 51.2 25.0 26.2
4.5 58 ± 3 64 ± 5 49.6 23.4 26.2
5 56 ± 3 55 ± 8 52.9 22.8 30.0
7 39 ± 5 59 ± 5 61.2 33.0 28.2
data from ref 17
H2O  lv
p (mJ/m2) = 51  lv
d (mJ/m2) = 21.8
CH2I2  lv
p (mJ/m2) = 1.3  lv
d (mJ/m2) = 49.5

   l m B p B (16)
and the values of the fitting parameters were: l =
0.0546, m = –0.0041 and p = –0.9257.
The evaluation of the slope and intercept of the
tangent to 
(B) in each experimentally considered
B value, allowed to determine the excess of poly-
mer (
1
sv ) and surfactant (
2
sv ) on the solid-vapor
interface as reported in Figure 8. Figure 8 shows
that while 
1
sv is almost zero whatever the SLS con-
tent, 
2
sv is negative for %SLS < 2% and then be-
comes positive. This means that the polymer sur-
face concentration is always equal to the bulk one,
while the SLS surface concentration is lower than
the bulk one for %SLS < 2% and it is bigger than
the bulk one for SLS  2%. Accordingly, for a bulk
concentration  2%, the surfactant should exert its
action at best.
The study of the surface properties was also
performed in the case of TTAB, while it was not
performed in the case of Lutrol as this surfactant
showed to be almost insoluble in K90 (see Figure
7). Table 2 reports the water (H2O) and the diiodo-
methane (CH2I2) contact angles relative to K90
TTAB films characterized by increasing amount of
TTAB up to 9%, i.e., just below TTAB solubility in
the K90-TTAB system (see Figure 6).
It can be seen that the addition of TTAB im-
plies a general reduction of H2O and a general in-
crease of CH2I2. Data shown in Table 2 reveal, also,
that the trend of cos() versus TTAB% (= f1), for
both water and diiodomethane, does not follows a
linear trend as it should be according to the
Cassie-Baxter equation (eq.(2)). Consequently, we
can conclude that only one phase exists at the
K90-TTAB film solid-vapor interface. This is in
agreement with what found by means of the bulk
characterization (see K90-TTAB phase diagram re-
ported in Figure 6). Table 2 also shows that, accord-
ing to eq.(5), the presence of TTAB causes an in-
crease of sv but this increase seems independent on
TTAB concentration (TTAB%). In addition, while
the dispersional component ( sv
d ) is un-affected by
the presence of TTAB, the polar component ( sv
p )
increases, but this increase is independent on
TTAB%. As the dispersional component is always
bigger than the polar one, we should conclude that
the effect of TTAB on surface wettability is smaller
than that of SLS, where the polar component re-
sulted similar, if not bigger, than the dispersional
one for SLS%  4%.
On the basis of the sv dependence on the
amount of SLS (see Table 2), it was possible evalu-
ating the excess of polymer (
1
sv ) and surfactant
( )
2
sv on the solid-vapor interface according to
eqs.(12)-(14). At this purpose TTAB content, ex-
pressed as mass fraction X 100, was converted into
molar concentration (moles/m3) knowing that poly-
mer and TTAB molecular weights are, respectively,
106 and 316.1 and that film density is, in the range
0 < TTAB%  9%, approximately equal to 1271.8
Kg/m3. As sv is, substantially, constant with
TTAB% (see Table 2) and, thus, with ln(c2), it turns
out that also 
 is constant with B. Accordingly, we
found that 
1
sv = 0 and 
2
sv = 4.2*10–5 moles/m2.
This means that there is no excess of K90 on film
surface, i.e. K90 surface concentration is equal to
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F i g . 8 – Trend of the polymer (
K
sv
90) and surfactant (
SLS
sv )
surface excess versus the SLS mass fraction X 100
T a b l e 2 – Water contact angle (H2O) ± standard deviation,
diiodomethane contact angle (CH2I2) ± standard deviation, po-
lar ( lv
p ) and dispersional ( lv
d ) liquid-vapor surface tension rel-
ative to water and diiodomethane, solid vapor surface tension
(sv), polar ( sv
p ) and dispersional ( sv
d ) solid-vapor surface ten-
sion relative to K90-TTAB films characterized by increasing
















0 55 ± 1 17 ± 1 64.2 19.0 45.2
0.5 36 ± 2 28 ± 3 71.1 29.3 41.7
1 32 ± 1 22 ± 2 74.5 30.6 43.8
2 35 ± 1 26 ± 1 72.0 29.6 42.4
3 35 ± 1 19 ± 1 73.3 28.8 44.5
5 38 ± 2 26 ± 1 70.7 28.3 42.4
7 37 ± 2 29 ± 1 70.6 29.1 41.5
9 34 ± 5 19 ± 1 73.8 29.3 44.5
data from ref 17
H2O  lv
p (mJ/m2) = 51.0  lv
d (mJ/m2) = 21.8
CH2I2  lv
p (mJ/m2) = 1.3  lv
d (mJ/m2) = 49.5
the bulk one. On the contrary, TTAB surface con-
centration is bigger than the bulk one. The compari-
son between TTAB and SLS surface behavior indi-
cates that for SLS%  2%, the surface excess com-
peting to SLS is around 300 times that competing to
TTAB. A further comparison between SLS and
TTAB performance can be led by evaluating their
behavior in aqueous solution/dispersion in presence
of K90 (water soluble; 10 mg/ml) and PVP-CL-M
(water insoluble; 10 mg/ml). In particular, Figures
9a and 9b, show, respectively, the variation of the
liquid-vapor surface tension (lv) referring to SLS
and TTAB aqueous solution containing K90 or
PVP-CL-M. Figure 9a reveals that the presence of
K90 sensibly alters the trend of lv versus the molar
concentration of SLS. This means that there is an
interaction between K90 and SLS. On the contrary,
as the presence of PVP-CL-M does not affect the
trend of lv versus the concentration of SLS, we can
conclude that interaction between SLS and
PVP-CL-M is negligible. Figure 9b, conversely,
demonstrates that the interaction between TTAB
and K90 or PVP-CL-M is negligible (no modifica-
tion of the lv trend versus TTAB molar concentra-
tion). Despite both SLS and TTAB demonstrated to
sensibly reduce the water contact angle on
nimesulide (69.5 ± 9) when added to water at 1%
(w/w) (SLS = 21 ± 2; TTAB = 22 ± 2), in the light of
the above consideration and those relative to the
surfactant-polymer films, we decided to explore the
effect of SLS on nimesulide release kinetics from
nimesulide/PVP-CL-M/SLS co-ground systems
(11:32:1 w/w). It is worth underlying that in this
ternary system, the SLS mass fraction relative to
the PVP/SLS system is 3%, i.e., the minimum
surfactant mass fraction ensuring the maximum ef-
fect of surfactant (see Figure 8).
Figure 10 shows the release kinetics relative to
five different delivery systems. Gray line, repre-
senting the release kinetics (dissolution) of pure
nimesulide, shows that nimesulide concentration is
very low and only after, about, 13 minutes it can be
detected. Correctly, nimesulide concentration in the
release environment (Cr) never exceeds the water
solubility that is 9 g/ml5.
Dashed thin line shows the behavior competing
to the physical mixture composed by nimesuli-
de/PVP-CL-M. It is evident that the addition of the
polymer, although cross-linked and, thus, insoluble,
can considerably increase the release kinetics (this
effect has been observed also for many other
crosslinked polymers). Accordingly, after 20 min-
utes, Cr approaches nimesulide solubility. Correctly,
the physical mixture obtained by adding SLS to
nimesulide and PVP-CL-M shows a higher release
kinetics (dotted thick line). Indeed, nimesulide dis-
solution takes now advantage not only by the pres-
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F i g . 9 a – Variation of the liquid-vapor surface tension (lv)
referring to pure SLS aqueous solutions (black circles) and to
SLS aqueous solutions containing K90 (gray circles) or
PVP-CL-M (white circles) at a concentration of 10 mg/ml
F i g . 9 b – Variation of the liquid-vapor surface tension (lv)
referring to pure TTAB aqueous solutions (black circles) and to
TTAB aqueous solutions containing K90 (gray circles) or
PVP-Clm (white circles) the scarce wettability
F i g . 1 0 – Release kinetics relative to the five different de-
livery systems studied. Cr is the nimesulide concentration in the
release environment, while t is time
ence of the polymer but also by the presence of the
surfactant. It is clearly evident that when the physi-
cal mixtures made up by nimesulide/PVP-CL-M
and by nimesulide/PVP-CL-M/SLS undergo
co-grinding, the release kinetics is enormously in-
creased (thick and thin continuous lines, respec-
tively). The differences existing among these two
release patterns can be explained in terms of surface
and bulk properties. Indeed, the presence of SLS,
increasing system wettability, reflects into a higher
release kinetics up to 40 seconds. Then, nimesuli-
de/PVP-CL-M exhibits a higher release kinetics.
This can be explained reminding that, in this sys-
tem, nimesulide is present only in nano-crystalline
or amorphous form (as demonstrated by DSC anal-
ysis, data not shown) and it is well known that
nano-crystalline or amorphous drug are associated
to higher solubility4,5,7. On the contrary, in the
nimesulide/PVP-CL-M/SLS system, part of the
drug is still present in the original macro-crystals
(as demonstrated by DSC analysis, data not shown).
As macro-crystals solubility is considerably lower
than that competing to nano-crystals and amor-
phous drug, the global driving force governing the
release kinetics is smaller than that competing to
nimesulide/PVP-CL-M.
Finally, Figures 11 shows a picture of the ni-
mesulide/PVP-CL-M/SLS system after 2h co-grind-
ing. It is possible to distinguish the small acicular
nimesulide crystals from the polymer-surfactant
globular structures.
Conclusions
This paper proves that the addition of a proper
surfactant can enhance the performance of
co-ground drug-polymer systems reducing the
problems connected with system wettability. Obvi-
ously, apart from other important aspects (drug sol-
ubility, particle size distribution and so on), the re-
lease kinetics depends not only on surface proper-
ties (wettability) but also on bulk properties (drug
status: macro-crystals, nano-crystals or amorphous).
At this purpose, the surface properties play a more
and more important role when the drug amount in-
creases. Typically, wettability can be a rate limiting
factor when the drug/polymer ratio is  1/3. Of
course this is not a general rule as this threshold de-
pends on the wettability of the drug. In general, this
limit is sound for drug characterized by a contact
angle with water around 70°.
The selection of the proper surfactant requires
the study of both the bulk and surface properties of
the polymer-surfactant system. Typically, DSC and
X rays are useful techniques to study bulk proper-
ties as they allow determining the solubility of the
surfactant in the polymer. Conversely, contact angle
measurement is fundamental for the determination
of the polar and dispersional components of the
solid-vapor surface tension jointly with the excess
of polymer and drug at the solid-vapor interface.
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